Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.97 USD | +1.14% | -7.22% | +146.75% |
05-28 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
05-15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.75% | 923M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+2.18% | 22.67B | |
-10.09% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Arcutis Biotherapeutics, Inc. Appoints Mas Matsuda as Corporate Secretary